J. Van Beek et al., Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death, NEUROREPORT, 12(2), 2001, pp. 289-293
The anaphylatoxin C3a is a potent inflammatory polypeptide released at site
s of complement activation. To test whether C3a might alter neuronal outcom
e following an ischemic insult, we determined the effects of purified human
C3a on murine primary cortical cell cultures exposed to apoptotic or excit
otoxic paradigms. C3a prevented neither serum deprivation-induced apoptotic
neuronal death, nor AMPA/kainate-mediated excitotoxicity. However, in mixe
d cultures of neurons and astrocytes, Ca dose-dependently protected neurons
against NMDA toxicity (47% neuroprotection using 100 nM C3a, p< 0.01, n =
12). The neuroprotective effect of C3a was observable only in the presence
of astrocytes. These observations suggest that C3a is involved in excitotox
icity-mediated neuronal death through astrocyte stimulation and extend its
role beyond immune functions. NeuroReport 12:289-293 (C) 2001 Lippincott Wi
lliams & Wilkins.